Aridis Pharmaceuticals Inc (ARDS)
0.0615
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Aridis Pharmaceuticals 1 Year Total Returns (Daily): -62.39% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -62.39% |
May 02, 2024 | -64.20% |
May 01, 2024 | -67.58% |
April 30, 2024 | -66.63% |
April 29, 2024 | -68.52% |
April 26, 2024 | -65.79% |
April 25, 2024 | -69.63% |
April 24, 2024 | -72.34% |
April 23, 2024 | -72.71% |
April 22, 2024 | -72.28% |
April 19, 2024 | -73.43% |
April 18, 2024 | -74.37% |
April 17, 2024 | -71.97% |
April 16, 2024 | -67.95% |
April 15, 2024 | -68.18% |
April 12, 2024 | -67.39% |
April 11, 2024 | -67.17% |
April 10, 2024 | -69.10% |
April 09, 2024 | -74.58% |
April 08, 2024 | -74.28% |
April 05, 2024 | -71.15% |
April 04, 2024 | -73.03% |
April 03, 2024 | -74.24% |
April 02, 2024 | -76.76% |
April 01, 2024 | -77.24% |
Date | Value |
---|---|
March 28, 2024 | -80.10% |
March 27, 2024 | -80.83% |
March 26, 2024 | -81.48% |
March 25, 2024 | -80.52% |
March 22, 2024 | -78.52% |
March 21, 2024 | -79.44% |
March 20, 2024 | -80.09% |
March 19, 2024 | -78.54% |
March 18, 2024 | -79.86% |
March 15, 2024 | -80.68% |
March 14, 2024 | -80.09% |
March 13, 2024 | -85.92% |
March 12, 2024 | -82.58% |
March 11, 2024 | -83.02% |
March 08, 2024 | -85.14% |
March 07, 2024 | -85.79% |
March 06, 2024 | -85.90% |
March 05, 2024 | -86.25% |
March 04, 2024 | -86.16% |
March 01, 2024 | -85.49% |
February 29, 2024 | -86.31% |
February 28, 2024 | -86.35% |
February 27, 2024 | -86.96% |
February 26, 2024 | -87.87% |
February 23, 2024 | -87.52% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.24%
Minimum
Sep 13 2023
66.59%
Maximum
Dec 14 2020
-48.77%
Average
-56.78%
Median
Nov 20 2019
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -90.79% |
Palatin Technologies Inc | -3.65% |
iBio Inc | -90.87% |
Theriva Biologics Inc | -37.06% |
Oragenics Inc | -59.32% |